IASO S.A. operates hospitals, and a recovery and rehabilitation center in Europe. More Details
Mediocre balance sheet unattractive dividend payer.
Share Price & News
How has IASO's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IASO is not significantly more volatile than the rest of Greek stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: IASO's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: IASO exceeded the Greek Healthcare industry which returned 11.5% over the past year.
Return vs Market: IASO underperformed the Greek Market which returned 39.8% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is IASO's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 years ago | Simply Wall StIASO's (ATH:IASO) Wonderful 454% Share Price Increase Shows How Capitalism Can Build Wealth
2 years ago | Simply Wall StDoes IASO S.A. (ATH:IASO) Have A Volatile Share Price?
2 years ago | Simply Wall StShould You Worry About IASO S.A.’s (ATH:IASO) ROCE?
Is IASO undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: IASO (€1.5) is trading above our estimate of fair value (€0.69)
Significantly Below Fair Value: IASO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IASO is unprofitable, so we can't compare its PE Ratio to the XE Healthcare industry average.
PE vs Market: IASO is unprofitable, so we can't compare its PE Ratio to the Greek market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IASO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IASO is good value based on its PB Ratio (1.4x) compared to the XE Healthcare industry average (2.3x).
How is IASO forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IASO has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has IASO performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IASO is currently unprofitable.
Growing Profit Margin: IASO is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IASO is unprofitable, and losses have increased over the past 5 years at a rate of 31.6% per year.
Accelerating Growth: Unable to compare IASO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IASO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (22.3%).
Return on Equity
High ROE: IASO has a negative Return on Equity (-0.69%), as it is currently unprofitable.
How is IASO's financial position?
Financial Position Analysis
Short Term Liabilities: IASO's short term assets (€54.7M) exceed its short term liabilities (€30.4M).
Long Term Liabilities: IASO's short term assets (€54.7M) do not cover its long term liabilities (€81.9M).
Debt to Equity History and Analysis
Debt Level: IASO's debt to equity ratio (53.8%) is considered high.
Reducing Debt: IASO's debt to equity ratio has reduced from 164.3% to 53.8% over the past 5 years.
Debt Coverage: IASO's debt is well covered by operating cash flow (25.7%).
Interest Coverage: IASO is unprofitable, therefore interest payments are not well covered by earnings.
What is IASO current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IASO's dividend (3.33%) is higher than the bottom 25% of dividend payers in the Greek market (1.71%).
High Dividend: IASO's dividend (3.33%) is low compared to the top 25% of dividend payers in the Greek market (3.93%).
Stability and Growth of Payments
Stable Dividend: IASO's dividend payments have been volatile in the past 10 years.
Growing Dividend: IASO's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: IASO is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Paraskevas P. Petropoulos serves as Chief Executive Officer of IASO S.A. Mr. Petropoulos served as Managing Director of Iaso SA. He served as 2nd Vice-Chairman of Iaso SA. He also served as Executive D...
Experienced Management: IASO's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Experienced Board: IASO's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
IASO S.A.'s company bio, employee growth, exchange listings and data sources
- Name: IASO S.A.
- Ticker: IASO
- Exchange: ATSE
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €159.757m
- Shares outstanding: 121.95m
- Website: https://www.iaso.gr
Number of Employees
- IASO S.A.
- 37-39, Kifissias Avenue
- 151 23
IASO S.A. operates hospitals, and a recovery and rehabilitation center in Europe. The company offers obstetrics and gynecology services, including gynecological oncology, endoscopic surgery, and pediatric ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/07 16:22|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.